{
    "nct_id": "NCT04545697",
    "official_title": "mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate Cancer: a Feasibility Trial of a Patient Decision Support Intervention",
    "inclusion_criteria": "1. Prostate cancer of any histology.\n2. Metastatic castrate-resistant Prostate Cancer (mCRPC)\n3. Progression per any Prostate Cancer Working Group 3(PCWG3) criterion.\n4. Has never received chemotherapy\n5. Currently receiving or has previously received any androgen-signaling inhibitors (ASI) (abiraterone, enzalutamide, apalutamide, or darolutamide) that was discontinued due to progression\n6. 18 years of age or older.\n7. Able to read, speak, and write in English.\n8. Has an upcoming genitourinary (GU) medical oncology appointment (in-person or Zoom video visit) at University of California, San Francisco (UCSF) within 7-60 days of enrollment.\n9. Has access to and ability to use an iPhone (iOS) or Android smartphone.\n10. Patient's UCSF oncology provider agrees to be recorded.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Lack of decision-making capacity to provide consent to this trial.\n2. Uncorrectable hearing or visual impairment hindering the ability to perform necessary tasks in the trial.\n3. Any neurocognitive or psychiatric disorder hindering the ability to perform necessary tasks in the trial.",
    "miscellaneous_criteria": ""
}